This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jubilant Generics Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Bidyut Biswas: Innovator in Pharmaceutical Chemistry
Introduction
Bidyut Biswas is a notable inventor based in Noida, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of angiotensin receptor blockers. His work is characterized by a focus on creating processes that enhance the safety and efficacy of pharmaceutical compounds.
Latest Patents
Bidyut Biswas holds a patent for the "Preparation of angiotensin receptor blockers or pharmaceutically acceptable salts thereof." This invention relates to a process for preparing angiotensin receptor blockers, specifically Losartan and its potassium salt, while ensuring that the azido impurities are kept below 10 ppm. The patent outlines a simple, economical, and industrially efficient method for producing these important pharmaceutical compounds.
Career Highlights
He is currently associated with Jubilant Generics Limited, where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the production methods of critical medications, thereby contributing to public health.
Collaborations
Throughout his career, Bidyut has collaborated with several professionals, including Saji Thomas and Rajendra Shekhawat. These collaborations have fostered a productive environment for innovation and development in pharmaceutical research.
Conclusion
Bidyut Biswas exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the preparation of angiotensin receptor blockers, highlight the importance of research and development in improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile